SPARC Stock/Share Prices, Buy and Sell SPARC BSE Stocks

Market Snapshot

BSE Sensex: 48803.68 0.53%
BSE 500: 19483.68 0.42%
BSE 200: 6250.48 0.48%
BSE 100: 14756.53 0.48%
BSE Mid-Cap: 19923.58 -0.10%
BSE Small-Cap: 20799.69 -0.03%
BANKEX: 36473.15 1.07%
BSE IT Sector: 26747.21 0.02%
Nifty 50: 14581.45 0.53%
Nifty 500: 12237.6 0.42%
Nifty 200: 7625.05 0.49%
Nifty 100: 14719.25 0.55%
Nifty Midcap 100: 23530 0.06%
Nifty Small 100: 8171 -0.19%
Nifty IT: 26010.85 0.62%
Nifty PSU Bank: 2050.8 -1.29%

News:

Wipro Q4 PAT rises 28% YoY to ...
Tinplate Company spurts on ste...
5paisa Capital vaults after bo...
Hero MotoCorp expands digital ...
Indian Overseas Bank leads los...

Sun Pharma Advanced Research Company Ltd NSE / BSE
Miscellaneous, Small Cap

Invest

15 Apr 2021 | 03:59 PM

161.65

-0.50 (-0.31%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

17.27%

Return (1Y)

Underperformed S&P BSE Healthcare by 35.76%
More Volatile

2.57%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 1.32%
Not so consistent

4/12

Months

underperformed S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

210

123

News & Announcements

Sun Pharma Advanced Research Company to convene EGM
12 days ago

Sun Pharma Advanced Research Company to convene EGM

03 - Apr - 2021 12:00 AM | 12 days ago

Sun Pharma Advanced Research Company announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 26 April 2021.
Powered by Capital Market - Live News
SPARC update on Taclantis™
51 days ago

SPARC update on Taclantis™

23 - Feb - 2021 12:00 AM | 51 days ago

Sun Pharma Advanced Research Company announced that the Office of New Drugs (OND) of the U.S. Food and DrugAdministration (FDA) has denied the Company's appeal of the Complete Response Letter inrelation to the New Drug Application (NDA) for Taclantis™.
In its Appeal Denied letter, the OND requested the conduct of a new Phase 3 study in metastatic breast cancer patients to support any potential resubmission of theTaclantis™ NDA. The Company will review FDA's response and decide on appropriate nextsteps soon.
Powered by Capital Market - Live News
Sun Pharma Advanced Research Company reports standalone net loss of Rs 67.62 crore in the December 2020 quarter
65 days ago

Sun Pharma Advanced Research Company reports standalone net loss of Rs 67.62 crore in the December 2020 quarter

09 - Feb - 2021 12:00 AM | 65 days ago

Net Loss of Sun Pharma Advanced Research Company reported to Rs 67.62 crore in the quarter ended December 2020 as against net loss of Rs 55.51 crore during the previous quarter ended December 2019. Sales rose 11.28% to Rs 21.81 crore in the quarter ended December 2020 as against Rs 19.60 crore during the previous quarter ended December 2019.
Particulars Quarter Ended
Dec. 2020 Dec. 2019 % Var.
Sales 21.81 19.60 11
OPM % -288.67 -274.03 -
PBDT -64.86 -53.26 -22
PBT -67.62 -55.51 -22
NP -67.62 -55.51 -22
Powered by Capital Market - Live News
Sun Pharma Advanced Research Company to announce Quarterly Result
75 days ago

Sun Pharma Advanced Research Company to announce Quarterly Result

30 - Jan - 2021 12:00 AM | 75 days ago

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on 8 February 2021.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Sun Pharma Advanced Research Company Ltd has increased by 5.22% since past 3 Months
MF shareholding in Sun Pharma Advanced Research Company Ltd has increased by 80.77% since past 3 Months
FII shareholding in Sun Pharma Advanced Research Company Ltd has decreased by -3.55% since past 1 Year
MF shareholding in Sun Pharma Advanced Research Company Ltd has increased by 193.75% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2020	Dec. 2019	% Var.
Sales	21.81	19.60	11
OPM %	-288.67	-274.03	-
PBDT	-64.86	-53.26	-22
PBT	-67.62	-55.51	-22
NP	-67.62	-55.51	-22

General Notifications

My Notifications

Research Notifications

Sun Pharma Advanced Research Company Ltd NSE / BSE Miscellaneous, Small Cap

161.65 -0.50 (-0.31%)

News & Announcements

Price vs Volume

Stock Trivia

Sun Pharma Advanced Research Company Ltd NSE / BSE
Miscellaneous, Small Cap

161.65

-0.50 (-0.31%)